Search research articles
Contact Us
Filters
Showing results (121-130 of 302) with videos related to
Page
of 31
Sort By:
Science China. Life Sciences
|
December 13, 2012
Computational analysis of deleterious missense mutations in aspartoacylase that cause Canavan's disease
K Sreevishnupriya, P Chandrasekaran, A Senthilkumar, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2015
A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258)
Jeffrey R Infante, Ramesh K Ramanathan, Daniel George, et al.
Investigational New Drugs
|
December 10, 2009
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Anne M Traynor, James P Thomas, Ramesh K Ramanathan, et al.
Pharmacotherapy
|
October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites
B J Delauter, R K Ramanathan, M J Egorin, et al.
Pancreas
|
November 15, 2016
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study
Volker Kunzmann, Ramesh K Ramanathan, David Goldstein, et al.
Applied Physics. B, Lasers and Optics
|
September 1, 2015
Autonomous field measurements of CO<sub>2</sub> in the atmospheric column with the miniaturized laser heterodyne radiometer (Mini-LHR)
H R Melroy, E L Wilson, G B Clarke, et al.
Investigational New Drugs
|
May 2, 2012
Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET
Jeffrey R Infante, Terence Rugg, Michael Gordon, et al.
Physical Review Letters
|
June 24, 2023
Wideband Direct Detection Constraints on Hidden Photon Dark Matter with the QUALIPHIDE Experiment
K Ramanathan, N Klimovich, R Basu Thakur, et al.
The Journal of Laboratory and Clinical Medicine
|
February 7, 2006
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma
Amanda F Baker, Tomislav Dragovich, Wendy R Tate, et al.
BMC Cancer
|
July 15, 2016
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Pashtoon M Kasi, Daisuke Kotani, Michael Cecchini, et al.
Page
of 31
Search research articles
Search
Showing results (121-130 of 302) with videos related to
Sort By:
Page
of 31
Science China. Life Sciences
|
December 13, 2012
Computational analysis of deleterious missense mutations in aspartoacylase that cause Canavan's disease
K Sreevishnupriya, P Chandrasekaran, A Senthilkumar, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2015
A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258)
Jeffrey R Infante, Ramesh K Ramanathan, Daniel George, et al.
Investigational New Drugs
|
December 10, 2009
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Anne M Traynor, James P Thomas, Ramesh K Ramanathan, et al.
Pharmacotherapy
|
October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites
B J Delauter, R K Ramanathan, M J Egorin, et al.
Pancreas
|
November 15, 2016
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study
Volker Kunzmann, Ramesh K Ramanathan, David Goldstein, et al.
Applied Physics. B, Lasers and Optics
|
September 1, 2015
Autonomous field measurements of CO<sub>2</sub> in the atmospheric column with the miniaturized laser heterodyne radiometer (Mini-LHR)
H R Melroy, E L Wilson, G B Clarke, et al.
Investigational New Drugs
|
May 2, 2012
Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET
Jeffrey R Infante, Terence Rugg, Michael Gordon, et al.
Physical Review Letters
|
June 24, 2023
Wideband Direct Detection Constraints on Hidden Photon Dark Matter with the QUALIPHIDE Experiment
K Ramanathan, N Klimovich, R Basu Thakur, et al.
The Journal of Laboratory and Clinical Medicine
|
February 7, 2006
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma
Amanda F Baker, Tomislav Dragovich, Wendy R Tate, et al.
BMC Cancer
|
July 15, 2016
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Pashtoon M Kasi, Daisuke Kotani, Michael Cecchini, et al.
Page
of 31